S. Seidu Et Al. , "2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care," Primary Care Diabetes , vol.16, no.2, pp.223-244, 2022
Seidu, S. Et Al. 2022. 2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care. Primary Care Diabetes , vol.16, no.2 , 223-244.
Seidu, S., Cos, X., Brunton, S., Harris, S., Jansson, S., Mata-Cases, M., ... Neijens, A.(2022). 2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care. Primary Care Diabetes , vol.16, no.2, 223-244.
Seidu, S. Et Al. "2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care," Primary Care Diabetes , vol.16, no.2, 223-244, 2022
Seidu, S. Et Al. "2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care." Primary Care Diabetes , vol.16, no.2, pp.223-244, 2022
Seidu, S. Et Al. (2022) . "2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care." Primary Care Diabetes , vol.16, no.2, pp.223-244.
@article{article, author={S. Seidu Et Al. }, title={2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care}, journal={Primary Care Diabetes}, year=2022, pages={223-244} }